Polen Capital Adaptive Biotechnologies Corp Transaction History
Polen Capital Management LLC
- $30.8 Billion
- Q3 2025
A detailed history of Polen Capital (Polen Capital Management LLC) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Polen Capital Management LLC holds 291,197 shares of ADPT stock, worth $4.11 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
291,197
Previous 142,257
104.7%
Holding current value
$4.11 Million
Previous $1.66 Million
162.88%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ADPT
# of Institutions
290Shares Held
147MCall Options Held
23.5KPut Options Held
33.3K-
Viking Global Investors LP30MShares$423 Million1.27% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$164 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$159 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN5.97MShares$84.2 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.3.65MShares$51.5 Million0.59% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $2.01B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...